Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neomycin | 36 | 2019 | 56 | 9.540 |
Why?
|
| DNA | 26 | 2017 | 597 | 6.100 |
Why?
|
| Aminoglycosides | 15 | 2019 | 54 | 5.550 |
Why?
|
| Bisbenzimidazole | 11 | 2019 | 13 | 4.510 |
Why?
|
| RNA | 12 | 2019 | 171 | 3.900 |
Why?
|
| Anti-Bacterial Agents | 15 | 2021 | 1026 | 3.130 |
Why?
|
| Nucleic Acid Conformation | 18 | 2015 | 92 | 2.870 |
Why?
|
| Binding Sites | 22 | 2021 | 631 | 2.010 |
Why?
|
| Nucleic Acids | 6 | 2019 | 16 | 1.890 |
Why?
|
| RNA, Viral | 4 | 2016 | 93 | 1.730 |
Why?
|
| Benzimidazoles | 4 | 2017 | 128 | 1.710 |
Why?
|
| Intercalating Agents | 6 | 2013 | 7 | 1.560 |
Why?
|
| G-Quadruplexes | 4 | 2013 | 5 | 1.460 |
Why?
|
| HIV Long Terminal Repeat | 4 | 2016 | 8 | 1.450 |
Why?
|
| Spectrometry, Fluorescence | 6 | 2019 | 112 | 1.420 |
Why?
|
| Topoisomerase I Inhibitors | 2 | 2019 | 8 | 1.280 |
Why?
|
| Escherichia coli | 4 | 2021 | 368 | 1.220 |
Why?
|
| DNA, B-Form | 3 | 2017 | 3 | 1.220 |
Why?
|
| Ribosomes | 5 | 2021 | 23 | 1.200 |
Why?
|
| Circular Dichroism | 13 | 2019 | 99 | 1.170 |
Why?
|
| Models, Molecular | 17 | 2021 | 546 | 1.140 |
Why?
|
| Fluorescent Dyes | 2 | 2019 | 191 | 1.130 |
Why?
|
| Amino Sugars | 2 | 2016 | 12 | 1.060 |
Why?
|
| Pyrenes | 4 | 2018 | 15 | 1.050 |
Why?
|
| Ligands | 10 | 2019 | 317 | 1.040 |
Why?
|
| Peptide Library | 2 | 2015 | 16 | 1.030 |
Why?
|
| Calorimetry | 9 | 2019 | 21 | 0.990 |
Why?
|
| Molecular Structure | 11 | 2017 | 397 | 0.980 |
Why?
|
| Structure-Activity Relationship | 12 | 2021 | 420 | 0.960 |
Why?
|
| Thermodynamics | 8 | 2014 | 162 | 0.910 |
Why?
|
| AT Rich Sequence | 3 | 2015 | 5 | 0.890 |
Why?
|
| Drug Resistance, Bacterial | 4 | 2021 | 98 | 0.880 |
Why?
|
| Framycetin | 4 | 2018 | 4 | 0.880 |
Why?
|
| Spectrophotometry, Ultraviolet | 7 | 2014 | 79 | 0.850 |
Why?
|
| Biological Assay | 2 | 2013 | 88 | 0.850 |
Why?
|
| Kinetics | 10 | 2021 | 1047 | 0.820 |
Why?
|
| Fluorescein | 3 | 2016 | 15 | 0.810 |
Why?
|
| High-Throughput Screening Assays | 3 | 2015 | 48 | 0.740 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2018 | 92 | 0.740 |
Why?
|
| Acinetobacter baumannii | 1 | 2019 | 22 | 0.680 |
Why?
|
| DNA, A-Form | 2 | 2016 | 2 | 0.670 |
Why?
|
| Kanamycin | 1 | 2019 | 11 | 0.660 |
Why?
|
| Telomere | 3 | 2013 | 59 | 0.640 |
Why?
|
| RNA, Ribosomal | 2 | 2017 | 11 | 0.610 |
Why?
|
| Microbial Sensitivity Tests | 7 | 2017 | 226 | 0.600 |
Why?
|
| Poly A | 3 | 2010 | 14 | 0.600 |
Why?
|
| Anthraquinones | 2 | 2017 | 18 | 0.590 |
Why?
|
| Staphylococcal Infections | 1 | 2018 | 156 | 0.580 |
Why?
|
| Base Sequence | 7 | 2015 | 1015 | 0.570 |
Why?
|
| Nucleic Acid Denaturation | 6 | 2013 | 16 | 0.560 |
Why?
|
| Nucleic Acid Heteroduplexes | 4 | 2011 | 7 | 0.530 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 1447 | 0.500 |
Why?
|
| Anti-Infective Agents | 1 | 2017 | 166 | 0.500 |
Why?
|
| Temperature | 6 | 2017 | 341 | 0.480 |
Why?
|
| Carbohydrate Sequence | 5 | 2015 | 45 | 0.470 |
Why?
|
| Carbohydrates | 1 | 2014 | 57 | 0.470 |
Why?
|
| HIV-1 | 2 | 2013 | 177 | 0.460 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2013 | 90 | 0.440 |
Why?
|
| Peptides | 1 | 2015 | 455 | 0.420 |
Why?
|
| Phosphorothioate Oligonucleotides | 1 | 2012 | 2 | 0.420 |
Why?
|
| Triazoles | 2 | 2015 | 43 | 0.410 |
Why?
|
| Drug Delivery Systems | 3 | 2011 | 236 | 0.410 |
Why?
|
| Dimerization | 5 | 2015 | 99 | 0.410 |
Why?
|
| Polymers | 1 | 2014 | 244 | 0.400 |
Why?
|
| Sisomicin | 2 | 2021 | 2 | 0.390 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2015 | 618 | 0.390 |
Why?
|
| Molecular Conformation | 4 | 2016 | 128 | 0.390 |
Why?
|
| Perylene | 1 | 2011 | 4 | 0.390 |
Why?
|
| Spectrophotometry | 1 | 2011 | 54 | 0.380 |
Why?
|
| Oxytricha | 1 | 2010 | 1 | 0.380 |
Why?
|
| DNA, Protozoan | 1 | 2010 | 8 | 0.370 |
Why?
|
| MicroRNAs | 1 | 2015 | 447 | 0.370 |
Why?
|
| Biological Products | 1 | 2011 | 78 | 0.370 |
Why?
|
| Transition Temperature | 4 | 2013 | 9 | 0.360 |
Why?
|
| Protein Binding | 4 | 2021 | 1027 | 0.360 |
Why?
|
| Oligonucleotides | 2 | 2007 | 34 | 0.340 |
Why?
|
| Phenanthridines | 1 | 2008 | 8 | 0.320 |
Why?
|
| Inhibitory Concentration 50 | 3 | 2017 | 73 | 0.320 |
Why?
|
| Chimera | 1 | 2008 | 33 | 0.310 |
Why?
|
| Binding, Competitive | 4 | 2015 | 165 | 0.290 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2014 | 35 | 0.290 |
Why?
|
| Tobramycin | 2 | 2021 | 38 | 0.290 |
Why?
|
| Hydrogen Bonding | 3 | 2011 | 67 | 0.290 |
Why?
|
| Antifungal Agents | 2 | 2017 | 108 | 0.290 |
Why?
|
| Molecular Docking Simulation | 2 | 2017 | 78 | 0.280 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 1745 | 0.260 |
Why?
|
| Humans | 17 | 2021 | 68618 | 0.250 |
Why?
|
| Providencia | 2 | 2021 | 2 | 0.240 |
Why?
|
| Thiourea | 3 | 2015 | 16 | 0.240 |
Why?
|
| Click Chemistry | 2 | 2016 | 7 | 0.230 |
Why?
|
| Acridines | 1 | 2003 | 2 | 0.230 |
Why?
|
| Lipids | 1 | 2005 | 298 | 0.230 |
Why?
|
| Transfection | 1 | 2005 | 782 | 0.220 |
Why?
|
| Quinoxalines | 1 | 2003 | 78 | 0.220 |
Why?
|
| Calorimetry, Differential Scanning | 2 | 2014 | 27 | 0.210 |
Why?
|
| Ribostamycin | 2 | 2011 | 2 | 0.190 |
Why?
|
| Paromomycin | 2 | 2011 | 3 | 0.190 |
Why?
|
| Acetyltransferases | 1 | 2021 | 49 | 0.190 |
Why?
|
| Candida albicans | 2 | 2017 | 39 | 0.190 |
Why?
|
| Small Molecule Libraries | 2 | 2011 | 53 | 0.180 |
Why?
|
| Substrate Specificity | 3 | 2021 | 234 | 0.180 |
Why?
|
| Ultraviolet Rays | 2 | 2013 | 130 | 0.170 |
Why?
|
| Bacterial Proteins | 1 | 2021 | 245 | 0.170 |
Why?
|
| Prostatic Neoplasms | 1 | 2005 | 778 | 0.160 |
Why?
|
| Drug Synergism | 1 | 2019 | 260 | 0.160 |
Why?
|
| Ribosomal Proteins | 1 | 2018 | 18 | 0.160 |
Why?
|
| Gram-Positive Bacteria | 1 | 2018 | 23 | 0.160 |
Why?
|
| Animals | 6 | 2018 | 20881 | 0.160 |
Why?
|
| Crystallography, X-Ray | 3 | 2021 | 190 | 0.160 |
Why?
|
| Drug Discovery | 1 | 2019 | 94 | 0.160 |
Why?
|
| Cell Membrane | 1 | 2019 | 525 | 0.150 |
Why?
|
| Isomerases | 1 | 2017 | 4 | 0.150 |
Why?
|
| Chemistry Techniques, Synthetic | 1 | 2017 | 7 | 0.150 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 1851 | 0.150 |
Why?
|
| Potassium Chloride | 2 | 2010 | 45 | 0.140 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2017 | 111 | 0.140 |
Why?
|
| RNA, Bacterial | 1 | 2017 | 30 | 0.140 |
Why?
|
| Escherichia coli Proteins | 1 | 2017 | 65 | 0.140 |
Why?
|
| Drug Resistance, Microbial | 1 | 2017 | 70 | 0.140 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 137 | 0.140 |
Why?
|
| Bacteria | 2 | 2015 | 193 | 0.140 |
Why?
|
| Viscosity | 2 | 2009 | 72 | 0.140 |
Why?
|
| MCF-7 Cells | 1 | 2015 | 80 | 0.130 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2015 | 43 | 0.130 |
Why?
|
| Osmolar Concentration | 2 | 2010 | 134 | 0.130 |
Why?
|
| Amino Acids | 1 | 2015 | 131 | 0.130 |
Why?
|
| Diazonium Compounds | 1 | 2014 | 1 | 0.120 |
Why?
|
| DNA Cleavage | 1 | 2014 | 2 | 0.120 |
Why?
|
| GC Rich Sequence | 1 | 2014 | 1 | 0.120 |
Why?
|
| Fluorenes | 1 | 2014 | 19 | 0.120 |
Why?
|
| Cattle | 2 | 2014 | 475 | 0.120 |
Why?
|
| RNA, Double-Stranded | 1 | 2014 | 13 | 0.120 |
Why?
|
| Benzothiazoles | 1 | 2013 | 14 | 0.110 |
Why?
|
| Serratia marcescens | 1 | 2013 | 5 | 0.110 |
Why?
|
| Enterobacter cloacae | 1 | 2013 | 4 | 0.110 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2013 | 13 | 0.110 |
Why?
|
| Phase Transition | 1 | 2013 | 10 | 0.110 |
Why?
|
| Quinolines | 1 | 2013 | 48 | 0.110 |
Why?
|
| DNA Damage | 1 | 2014 | 190 | 0.110 |
Why?
|
| Fluorescence | 1 | 2012 | 104 | 0.110 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2012 | 95 | 0.100 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2013 | 133 | 0.100 |
Why?
|
| Fungal Proteins | 1 | 2012 | 37 | 0.100 |
Why?
|
| Biomimetic Materials | 1 | 2012 | 20 | 0.100 |
Why?
|
| Endoribonucleases | 1 | 2012 | 22 | 0.100 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 175 | 0.100 |
Why?
|
| Aflatoxins | 1 | 2011 | 6 | 0.100 |
Why?
|
| Alkylation | 1 | 2011 | 26 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 322 | 0.100 |
Why?
|
| Polynucleotides | 1 | 2011 | 4 | 0.100 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2012 | 45 | 0.100 |
Why?
|
| Fluoresceins | 1 | 2011 | 31 | 0.100 |
Why?
|
| Carbazoles | 1 | 2011 | 46 | 0.100 |
Why?
|
| Mutation | 1 | 2017 | 1213 | 0.100 |
Why?
|
| Guanine | 1 | 2010 | 21 | 0.090 |
Why?
|
| Poly T | 1 | 2010 | 1 | 0.090 |
Why?
|
| Protein Denaturation | 1 | 2010 | 27 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 346 | 0.080 |
Why?
|
| Algorithms | 1 | 2014 | 1196 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 700 | 0.070 |
Why?
|
| Titrimetry | 1 | 2007 | 11 | 0.070 |
Why?
|
| Models, Chemical | 1 | 2008 | 155 | 0.070 |
Why?
|
| Nitrogen | 1 | 2007 | 57 | 0.070 |
Why?
|
| Carbohydrate Conformation | 1 | 2006 | 25 | 0.070 |
Why?
|
| Macromolecular Substances | 1 | 2006 | 122 | 0.070 |
Why?
|
| Surface Plasmon Resonance | 1 | 2006 | 50 | 0.070 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2006 | 85 | 0.060 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2005 | 20 | 0.060 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2005 | 29 | 0.060 |
Why?
|
| Cations | 1 | 2005 | 51 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2017 | 362 | 0.060 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 306 | 0.060 |
Why?
|
| Dialysis | 1 | 2003 | 30 | 0.060 |
Why?
|
| Poly dA-dT | 1 | 2003 | 1 | 0.060 |
Why?
|
| Magnesium Chloride | 1 | 2003 | 8 | 0.060 |
Why?
|
| Nucleosides | 1 | 2003 | 9 | 0.050 |
Why?
|
| Nucleotides | 1 | 2003 | 29 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2003 | 284 | 0.050 |
Why?
|
| Netilmicin | 1 | 2021 | 1 | 0.050 |
Why?
|
| Amikacin | 1 | 2021 | 13 | 0.050 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2021 | 8 | 0.050 |
Why?
|
| RNA, Transfer | 1 | 2021 | 10 | 0.050 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2021 | 10 | 0.050 |
Why?
|
| Methylation | 1 | 2021 | 56 | 0.050 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2021 | 57 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 85 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2021 | 357 | 0.050 |
Why?
|
| Male | 2 | 2017 | 37321 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2021 | 312 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 742 | 0.040 |
Why?
|
| Gene Expression | 1 | 2021 | 770 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2002 | 706 | 0.040 |
Why?
|
| Sterols | 1 | 2017 | 13 | 0.040 |
Why?
|
| Hemolysis | 1 | 2017 | 39 | 0.040 |
Why?
|
| Protein Unfolding | 1 | 2017 | 7 | 0.040 |
Why?
|
| Biofilms | 1 | 2017 | 72 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2017 | 326 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 499 | 0.030 |
Why?
|
| Urea | 1 | 2015 | 51 | 0.030 |
Why?
|
| Time Factors | 1 | 2017 | 4655 | 0.020 |
Why?
|
| Polyelectrolytes | 1 | 2000 | 1 | 0.010 |
Why?
|
| Polyamines | 1 | 2000 | 79 | 0.010 |
Why?
|